FindTrial
Sign In

To study the prevalence of sarcopenia in patients with chronic pancreatitis

To Study the Prevalence of Sarcopenia in patients with Chronic Pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/05/042478
Enrollment
100
Registered
2022-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K861- Other chronic pancreatitis

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient presented with diagnosis of chronic pancreatitis

Exclusion criteria

Exclusion criteria: Patients with a CT scan of inadequate quality for skeletal muscle mass segmentation patients with no registration of height at the time of CT examination patients with incomplete information on disease characteristics patients with active cancer or signs of decompensated chronic liver disease

Design outcomes

Primary

MeasureTime frame
To study the prevalence and risk factors for sarcopenia in patients with CP Timepoint: 11 months—

Secondary

MeasureTime frame
To determine the utility of a computed tomography (CT)-based method, based on psoas muscle measurements, for easy and clinical feasible diagnosis of sarcopenia Timepoint: 11 months—

Countries

India

Contacts

Public ContactDr Rishi Raman

Manipal Academy of Higher Education

rishiraman89@gmail.com9560058619

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026